Title	Publication Date	Language	Citations
When and How to Use PARP Inhibitors in Prostate Cancer: A Systematic Review of the Literature with an Update on On-Going Trials	2020/10/01	English	56
Patient-reported Outcomes Following Treatment of Localised Prostate Cancer and Their Association with Regret About Treatment Choices	2020/02/01	English	56
A Prospective Comparison of 18F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE)	2021/08/01	English	56
Functional and Oncologic Outcomes Between Open and Robotic Radical Prostatectomy at 24-month Follow-up in the Swedish LAPPRO Trial	2018/10/01	English	54
Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Meta-analysis of Oncologic, Perioperative, and Complication-related outcomes	2019/07/01	English	54
Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma	2020/06/01	English	54
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non–muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non–muscle-invasive Bladder Cancer Guidelines Panel Study	2021/04/01	English	53
Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review	2019/03/01	English	53
Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer	2021/06/01	English	52
Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis	2021/04/01	English	52
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD)	2021/12/01	English	52
Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes	2019/07/01	English	50
Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients	2018/09/01	English	50
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases	2018/05/01	English	50
A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer	2021/10/01	English	50
Analysis of Magnetic Resonance Imaging–directed Biopsy Strategies for Changing the Paradigm of Prostate Cancer Diagnosis	2020/02/01	English	50
Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA	2018/05/01	English	49
The Learning Curve for Magnetic Resonance Imaging/Ultrasound Fusion-guided Prostate Biopsy	2019/03/01	English	49
Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer	2020/08/01	English	49
Intermediate-risk Prostate Cancer: Stratification and Management	2020/06/01	English	48
Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel	2020/02/01	English	48
Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer	2018/06/01	English	47
COVID-19 and Bacillus Calmette-Guérin: What is the Link?	2020/06/01	English	47
Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma	2019/09/01	English	47
Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort	2020/06/01	English	46
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard	2022/02/01	English	46
Optimizing the Number of Cores Targeted During Prostate Magnetic Resonance Imaging Fusion Target Biopsy	2018/10/01	English	45
Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer	2019/03/01	English	45
Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients	2018/06/01	English	44
Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes	2018/12/01	English	43